Cell Therapy Center, Amman, Jordan - 01 Jan `23Stem-cell secretome treatment for vitiligo

Stem-cell secretome treatment for vitiligo

Official title: Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.

Status: Closed to new participants

Description:

University of Jordan enrolled about 13 participants. This experimental treatment uses cell-derived particles and signaling proteins intended to change inflammation and tissue repair. Researchers hope these signals will protect melanocytes and encourage pigment to return. Possible risks include injection or infusion reactions, allergy, inflammation, infection, and other effects that are not yet known. People ages 18 to 75 may qualify. The study is underway but is no longer accepting new participants.

Start date: January 01, 2023

Completion date: January 30, 2027

Organizer: University of Jordan

Contact: See contacts and locations in the ClinicalTrials.gov record

Link: https://clinicaltrials.gov/study/NCT06813027

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Stem-cell secretome treatment for vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions

  • Shall I take vitamin D for my vitiligo?

    Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be ideal for mo...

  • Awareness Days Similar to World Vitiligo Day

    World Vitiligo Day, celebrated annually on June 25 since 2012, is a significant event dedicated to raising awareness about vitiligo and supporting those affected by the conditio...

  • Is there a special diet for vitiligo?

    Recent research highlights the potential of diet and nutrition in managing vitiligo, offering an alternative where traditional therapies may be lacking. However, the relationshi...